Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gou-Teng-San in Episodic Migraine
NCT07496034Phase 3Recruiting
- Sponsor
- T-E Meds
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Gou-Teng-San in episodic migraine, sponsored by T-E Meds. Started Jul 2025; status: recruiting.
02
Drugs
Gou-Teng-San
03
Conditions
episodic migraine
Beyond the preview
Go deeper on NCT07496034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07496034.